A COMBINATION of aspirin and fish oil could be the best way to tackle chronic diseases such as arthritis, scientists have found.
The two work together to combat the inflammation responsible for a host of devastating illnesses, from heart disease and cancer to arthritis and Alzheimer’s.
Both low-dose aspirin and omega-3 fatty acids from fish are known to have an anti-inflammatory effect on their own. But research has shown that taken together they can control the overactive immune responses that are linked to long-term health problems.
Doctors have long hailed the benefits of aspirin and oily fish but exactly how they worked in the body to boost health was not fully known.
Now US researchers from the Brigham and Women’s Hospital and Harvard Medical School in Boston have shown that the breakthrough lies in their ability to combine and deliver a double blow to inflammation.
Aspirin helps trigger the production of key molecules called resolvins that are made naturally by the body from omega-3 fatty acids. These resolvins then shut off, or “resolve”, the inflammation that underlies the health conditions which blight the lives of millions.
Inflammation is the body’s natural response to injury and outside irritants. When something harmful or irritating affects a part of the body, there is a biological response to try to remove it, and the symptoms of inflammation show that the body is trying to heal itself.
But when there is no break from the irritants, for example because of a high-fat diet, too much body fat and smoking, the immune system can spiral out of control and increase the risk of disease.
When it stays out of control over the long term, inflammation becomes chronic and that is when it can damage heart valves and brain cells, trigger strokes and promote resistance to insulin, which leads to diabetes. It is also associated with the development of cancer.
Millions of people take a low-dose aspirin every day to stave off heart attacks and strokes.
The Latest on: Arthritis
[google_news title=”” keyword=”Arthritis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Arthritis
- Arthritis Patients - Cigna's Evernorth To Offer Humira Biosimilar At No Out-of-Pocket Coston April 26, 2024 at 11:41 am
Evernorth Health Services said its Accredo arm will make a Humira biosimilar available to patients with no out-of-pocket costs. Evernorth is a subsidiary of The Cigna Group (NYSE:CI). Beginning in ...
- AbbVie’s Q1 earnings beat expectations as arthritis drug boosts growthon April 26, 2024 at 5:17 am
Pharmaceuticals company AbbVie reported its Q1 financial results for 2024 today. AbbVie’s earnings came in at $1.37B, or $0.77 per share.
- AbbVie’s first-quarter results top expectations as arthritis drugs fuel growthon April 26, 2024 at 4:37 am
AbbVie on Friday reported first-quarter results that beat expectations even as sales of its blockbuster autoimmune drug Humira continued to fall.
- Biogen's Tofidence Gets Positive CHMP Opinion For Rheumatoid Arthritis,Juvenile Arthritis & COVID-19on April 25, 2024 at 6:48 pm
Biogen Inc. (BIIB) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA ...
- Sunset Zoo tiger receives groundbreaking new arthritis treatmenton April 25, 2024 at 1:49 pm
Beloved local tiger Hakim recently underwent groundbreaking arthritis treatment at Sunset Zoo. The 17-year-old tiger was treated at the Kansas State University College of Veterinary Medicine by Dr.
via Bing News